Skip to content
healthcare.dev

Jalyn

NDC 80725-809, DUTASTERIDE and TAMSULOSIN HYDROCHLORIDE, capsule, from Waylis Therapeutics.

Product NDC
80725-809
Status
Listed
Labeler
Waylis Therapeutics
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022460
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80725-809 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DUTASTERIDE.5 mg/1
  • TAMSULOSIN HYDROCHLORIDE.4 mg/1

Pharmacologic classes

5-alpha Reductase Inhibitor [EPC]; 5-alpha Reductase Inhibitors [MoA]; Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
80725-809-138072508091330 CAPSULE in 1 BOTTLE, PLASTIC (80725-809-13)
80725-809-598072508095990 CAPSULE in 1 BOTTLE, PLASTIC (80725-809-59)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aab9a2d4-5328-40f3-986f-e7753a928bc0

Use it

Look up 80725-809 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80725-809 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80725-809. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.